HF Msds
HF Msds
HF Msds
PRODUCT NAME:
OTHER/GENERIC NAMES:
PRODUCT USE:
Aqueous HF, Hydrofluoric Acid Solution, 49% HF, Ultra High Purity HF, Electronic Grade
HF
MANUFACTURER:
Honeywell International
Industrial Fluorines
101 Columbia Road
Box 1053
Morristown, New Jersey 07962-1053
2. COMPOSITION/INFORMATION ON INGREDIENTS
INGREDIENT NAME
Hydrofluoric Acid
Water
CAS NUMBER
7664-39-3
7732-18-5
WEIGHT %
49
51
Trace impurities and additional material names not listed above may also appear in the Regulatory Information Section 15
towards the end of the MSDS. These materials may be listed for local "Right-To-Know" compliance and for other
reasons.
3. HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW: Clear, colorless, corrosive fuming liquid with an
extremely acrid odor. May produce white fumes if spilled. Both liquid and vapor can
cause severe burns to all parts of the body. Specialized medical treatment is required for
all exposures.
Page 1 of 8
INHALATION:
Mild exposure: Can irritate nose, throat and respiratory system. Onset of symptoms may be
delayed for several hours.
Severe exposure: Can cause nose and throat burns, lung inflammation and pulmonary edema
(fluid in the lungs). Also results in other toxic effects including hypocalcemia (depletion of
calcium in the body) which if not properly treated can result in death.
INGESTION:
Can cause severe mouth, throat and stomach burns and may be fatal if swallowed. Even with
small amounts of dilute solutions, profound and possibly fatal hypocalcemia (depletion of
calcium in body) and systematic toxicity is likely to occur unless medical treatment is promptly
initiated.
DELAYED EFFECTS: The effects of contact with dilute solutions of hydrofluoric acid or its vapors may be
delayed. The potential delay in clinical signs or symptoms for dilute solutions is given
below:
HF Concentration
>50%
20%-50%
0%-20%
Delay in Symptoms
Immediately Apparent
1-8 hours
Up to 24 hours
Remove the victim from the contaminated area and immediately wash the burned area with plenty of water for a
minimum of 15 minutes. Limit washing to 5 minutes if treatment specific for HF exposure is available.
Remove all contaminated clothing while washing continuously. After thorough washing for at least 5 minutes,
the burned area should be immersed in a solution of 0.13% iced aqueous Zephiran Chloride until pain is
relieved. As an alternate first aid treatment, 2.5% calcium gluconate gel may be continuously massaged into the
burn area until the pain is relieved. For larger burns or burns treated with calcium gluconate gel (in which pain
is present longer than 30 minutes), a physician should inject 5% aqueous calcium gluconate beneath, around
and in the burned area. Use of local anesthetics is not recommended, as reduction in pain is an indicator of
effectiveness of treatment.
Page 2 of 8
Irrigate eyes for at least 15 minutes with copious quantities of water, keeping eyelids apart and away from
eyeballs during irrigation. Get competent medical attention immediately, preferably an eye specialist. If a
physician is not immediately available, apply one or two drops of 0.5% tetracaine hydrochloride solution, or
other aqueous topical ophthalmic anesthetic and continue irrigation. Do not use the solution described for skin
treatment. Use no oils or greases unless instructed to do so by a physician. Irrigate with 1% calcium gluconate
in normal saline for 1 to 2 hours to prevent or lessen corneal damage.
INHALATION:
INGESTION:
Move to fresh air. Keep the victim lying down, quiet and warm. Get competent medical attention
immediately. If breathing has stopped, start artificial respiration at once. An authorized person
should administer oxygen to a victim who is having difficulty breathing, until the victim is able to
breathe easily by himself. Do not give stimulants unless instructed to do so by a physician. Victim
should be examined by a physician and held under observation for at least 24 hours. Calcium
Gluconate, 2.5% in normal saline may be given by nebulizer with oxygen.
Drink large amounts of water to dilute. Do not induce vomiting. Several glasses of milk or several
ounces of milk of magnesia may be given for their soothing effect. Take victim to a doctor.
ADVICE TO PHYSICIAN:
For burns of large skin areas (greater than 25 square inches), for ingestion and for
significant inhalation exposure, severe systemic effects may occur. Monitor and correct
for hypocalcemia, cardiac arrhythmias, hypomagnesemia and hyperkalemia. In come
cases renal dialysis may be indicated. For certain burns, especially of the digits, use of
intra-arterial calcium gluconate may be indicated. For inhalation exposures, treat as
chemical pneumonia. Monitor for hypocalcemia. 2.5% calcium gluconate in normal
saline by nebulizer or by IPPB with 100% oxygen may decrease pulmonary damage.
Bronchodilators may also be administered.
Page 3 of 8
Page 4 of 8
INGREDIENT NAME
Hydrofluoric acid
ACGIH TLV
3 ppm CEILING
OSHA PEL
3 ppm (TWA)
OTHER LIMIT
3 mg(F)/g creatinine in
urine pre-shift
10 mg(F)/g creatinine
post-shift***
IDLH
OSHA STEL
6 ppm (15 min.)
30 ppm
AIHA Emergency Response Planning Guideline
ERPG-3
ERPG-1
ERPG-2
2 ppm
20 ppm
50 ppm
***
= Biological Exposure Index
OTHER EXPOSURE LIMITS FOR POTENTIAL DECOMPOSITION PRODUCTS: None
Page 5 of 8
=
=
=
Skin: 2% solution of HF was corrosive to rabbit skin with 1 hour exposure, but not with 1 minute exposure.
DELAYED (SUBCHRONIC AND CHRONIC) EFFECTS:
Prolonged exposure can cause bone and joint changes in humans. (Fluorosis Increased bone density and
mottling of teeth)
OTHER DATA: None
Page 6 of 8
None
SARA/CERCLA RQ (lbs)
100 as 100% HF
Spills or releases resulting in the loss of any ingredient at or above its RQ requires immediate notification to the
National Response Center [(800) 424-8802] and to your Local Emergency Planning Committee.
SECTION 311 HAZARD CLASS:
Immediate. Delayed
COMMENT
None
STATE RIGHT-TO-KNOW
In addition to the ingredients found in Section 2, the following are listed for state right-to-know purposes.
WEIGHT % COMMENT
INGREDIENT NAME
No ingredients in this section
ADDITIONAL REGULATORY INFORMATION: None
Page 7 of 8
January, 2002
January, 2001
CHANGES TO MSDS FROM PREVIOUS ISSUE DATE ARE DUE TO THE FOLLOWING:
Minor wording changes in Sections 1,3,4,6,7,8,10, & 13 for clarification. (Jan 02)
OTHER INFORMATION:
Page 8 of 8